Smiths Group is contracting with the UK Government for a significant ramp up in the production of its lifesaving Smiths Medical paraPAC plus ventilators.
Production will rapidly increase from hundreds a month to thousands a month to fulfill 10,000 units in response to the UK Government’s challenge to UK technology and engineering businesses to help save lives in the coronavirus pandemic, according to the company.
The paraPAC plus lightweight and portable ventilators deliver oxygen to the lungs of sick patients to help them breathe, taking some of the strain from the lungs, during emergencies, when transported to and around medical facilities, or wherever they are needed. The device is fully certified and used by medical professionals within the UK and overseas.
Smiths is working closely with the Ventilator Challenge UK Consortium to expand its supply chain capability, including Smiths own operations in Luton and many other leading UK Technology and Engineering companies across automotive, aerospace, industrial and F1.
In addition, Smiths Group confirms it is also in urgent discussions with potential partners around the world to make its ventilator technology available to support the global fight against COVID-19.
“It is our duty and an honor to be supporting the UK Government to save as many lives as possible. We are playing a key role working with the Ventilator Challenge UK Consortium to put in place the production and component capability to increase manufacturing of our lightweight portable ventilator as fast as possible,” said Andrew Reynolds Smith, CEO of Smiths Group.
